Security
Bausch Health Companies Inc. · BHC
BHCTSXCommon stockCurrentCIK 885590Updated Oct 30, 2026
Name history
Valeant Pharmaceuticals International, Inc. · through Jul 3, 2018BIOVAIL Corp · through Sep 27, 2010BIOVAIL CORP INTERNATIONAL · through Apr 7, 2010BIOVAIL CORPORATION INTERNATIONAL · through Jan 5, 2001
BHC price & chart
Loading TradingView…
TSX:BHC on TradingView ↗About the company
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information about Bausch Health, visit www.bauschhealth.com and connect with us on LinkedIn.
In the news
Bausch Health Announces US$50 Million Share Repurchase Program ↗
Recent filings
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
144 filing
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 26,824,000,000Source | 26,540,000,000Source | 24,794,000,000Source | 27,266,000,000Source | 26,495,000,000Source | 24,498,000,000Source | 26,421,000,000Source | 26,913,000,000Source | 26,366,000,000Source | 26,523,000,000Source | 27,350,000,000Source | 25,686,000,000Source |
| Property, Plant and Equipment, NetUSD | 2,026,000,000Source | 1,789,000,000Source | — | 1,994,000,000Source | 1,738,000,000Source | — | 1,882,000,000Source | 1,713,000,000Source | 2,074,000,000Source | 1,780,000,000Source | 1,707,000,000Source | 1,600,000,000Source |
| GoodwillUSD | 11,287,000,000Source | 11,171,000,000Source | 9,793,000,000Source | 11,298,000,000Source | 11,127,000,000Source | 9,807,000,000Source | 11,153,000,000Source | 11,160,000,000Source | 11,271,000,000Source | 11,087,000,000Source | 11,183,000,000Source | 11,547,000,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 4,830,000,000Source | 5,652,000,000Source | 4,179,000,000Source | 5,047,000,000Source | 5,903,000,000Source | 4,404,000,000Source | 5,297,000,000Source | 6,183,000,000Source | 4,643,000,000Source | 5,551,000,000Source | 6,456,000,000Source | 5,800,000,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 1,308,000,000Source | 719,000,000Source | 1,825,000,000Source | 1,727,000,000Source | 595,000,000Source | 1,299,000,000Source | 1,134,000,000Source | 733,000,000Source | 1,309,000,000Source | 1,181,000,000Source | 947,000,000Source | 564,000,000Source |
| Inventory, NetUSD | 1,598,000,000Source | 1,655,000,000Source | 1,602,000,000Source | 1,655,000,000Source | 1,612,000,000Source | 1,601,000,000Source | 1,613,000,000Source | 1,636,000,000Source | 1,629,000,000Source | 1,595,000,000Source | 1,544,000,000Source | 1,090,000,000Source |
| Assets, CurrentUSD | 6,249,000,000Source | 5,351,000,000Source | 6,522,000,000Source | 6,514,000,000Source | 5,211,000,000Source | 5,978,000,000Source | 5,732,000,000Source | 5,396,000,000Source | 6,157,000,000Source | 5,774,000,000Source | 5,596,000,000Source | 4,247,000,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 894,000,000Source | 852,000,000Source | 819,000,000Source | 906,000,000Source | 874,000,000Source | 874,000,000Source | 890,000,000Source | 957,000,000Source | 852,000,000Source | 838,000,000Source | 1,092,000,000Source | 776,000,000Source |
| Operating Lease, Right-of-Use AssetUSD | — | — | — | — | — | — | — | — | 215,000,000Source | 211,000,000Source | 185,000,000Source | 221,000,000Source |
| Other Assets, NoncurrentUSD | 382,000,000Source | 389,000,000Source | 358,000,000Source | 388,000,000Source | 329,000,000Source | 369,000,000Source | 380,000,000Source | 312,000,000Source | 378,000,000Source | 363,000,000Source | 307,000,000Source | 326,000,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 26,468,000,000Source | 26,782,000,000Source | 25,596,000,000Source | 27,119,000,000Source | 26,722,000,000Source | 25,580,000,000Source | 26,661,000,000Source | 27,087,000,000Source | 25,989,000,000Source | 26,845,000,000Source | 27,432,000,000Source | 25,426,000,000Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 10,515,000,000Source | 10,489,000,000Source | 10,544,000,000Source | 10,510,000,000Source | 10,483,000,000Source | 10,542,000,000Source | 10,508,000,000Source | 10,480,000,000Source | 10,516,000,000Source | 10,490,000,000Source | 10,423,000,000Source | 10,391,000,000Source |
| Retained Earnings (Accumulated Deficit)USD | -9,555,000,000Source | -9,917,000,000Source | -10,832,000,000Source | -9,734,000,000Source | -9,832,000,000Source | -11,090,000,000Source | -9,882,000,000Source | -9,842,000,000Source | -9,667,000,000Source | -9,824,000,000Source | -9,778,000,000Source | -9,186,000,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -1,800,000,000Source | -1,947,000,000Source | -1,825,000,000Source | -1,790,000,000Source | -2,007,000,000Source | -1,806,000,000Source | -2,029,000,000Source | -1,917,000,000Source | -1,760,000,000Source | -2,179,000,000Source | -1,881,000,000Source | -2,056,000,000Source |
| Stockholders' Equity Attributable to ParentUSD | -565,000,000Source | -1,174,000,000Source | -1,771,000,000Source | -764,000,000Source | -1,175,000,000Source | -2,059,000,000Source | -1,183,000,000Source | -1,115,000,000Source | -554,000,000Source | -1,279,000,000Source | -1,022,000,000Source | -692,000,000Source |
| Additional Paid in Capital, Common StockUSD | 275,000,000Source | 201,000,000Source | 342,000,000Source | 250,000,000Source | 181,000,000Source | 295,000,000Source | 220,000,000Source | 164,000,000Source | 357,000,000Source | 234,000,000Source | 214,000,000Source | 159,000,000Source |
| Liabilities and EquityUSD | 26,824,000,000Source | 26,540,000,000Source | 24,794,000,000Source | 27,266,000,000Source | 26,495,000,000Source | 24,498,000,000Source | 26,421,000,000Source | 26,913,000,000Source | 26,366,000,000Source | 26,523,000,000Source | 27,350,000,000Source | 25,686,000,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 4,793,000,000Source | 4,506,000,000Source | 4,544,000,000Source | 4,975,000,000Source | 4,369,000,000Source | 4,530,000,000Source | 4,256,000,000Source | 4,405,000,000Source | 4,180,000,000Source | 6,752,000,000Source | 4,302,000,000Source | 3,941,000,000Source |
| Operating Lease, Liability, CurrentUSD | — | — | — | — | — | — | — | — | 61,000,000Source | 58,000,000Source | 61,000,000Source | 50,000,000Source |
| Accounts Payable, CurrentUSD | 616,000,000Source | 667,000,000Source | 593,000,000Source | 627,000,000Source | 579,000,000Source | 593,000,000Source | 620,000,000Source | 642,000,000Source | 600,000,000Source | 656,000,000Source | 719,000,000Source | 521,000,000Source |
| Operating Lease, Liability, NoncurrentUSD | — | — | — | — | — | — | — | — | 167,000,000Source | 165,000,000Source | 148,000,000Source | 184,000,000Source |
| Deferred Income Tax Liabilities, NetUSD | 145,000,000Source | 169,000,000Source | 211,000,000Source | 144,000,000Source | 170,000,000Source | 179,000,000Source | 134,000,000Source | 170,000,000Source | 147,000,000Source | 128,000,000Source | 163,000,000Source | 202,000,000Source |
| Other Liabilities, NoncurrentUSD | 843,000,000Source | 805,000,000Source | 733,000,000Source | 877,000,000Source | 745,000,000Source | 763,000,000Source | 761,000,000Source | 751,000,000Source | 793,000,000Source | 713,000,000Source | 776,000,000Source | 741,000,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 921,000,000Source | 932,000,000Source | 969,000,000Source | 911,000,000Source | 948,000,000Source | 977,000,000Source | 943,000,000Source | 941,000,000Source | 931,000,000Source | 957,000,000Source | 940,000,000Source | 952,000,000Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 3,598,000,000Source | 3,386,000,000Source | 3,070,000,000Source | 3,469,000,000Source | 3,338,000,000Source | 3,037,000,000Source | 3,354,000,000Source | 3,225,000,000Source | 3,344,000,000Source | 3,422,000,000Source | 3,133,000,000Source | 2,988,000,000Source |
| Long-term Debt, Excluding Current Maturities | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source |
| Long-term Debt, Current MaturitiesUSD | 579,000,000Source | 453,000,000Source | 866,000,000Source | 879,000,000Source | 452,000,000Source | 889,000,000Source | 282,000,000Source | 538,000,000Source | 225,000,000Source | 2,674,000,000Source | 450,000,000Source | 432,000,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 20,463,000,000Source | 21,054,000,000Source | 19,875,000,000Source | 20,859,000,000Source | 21,208,000,000Source | 19,875,000,000Source | 21,228,000,000Source | 21,536,000,000Source | 20,592,000,000Source | 18,942,000,000Source | 21,938,000,000Source | 20,334,000,000Source |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | 181,000,000Source | -92,000,000Source | 260,000,000Source | 128,000,000Source | -1,431,000,000Source | -86,000,000Source | 120,000,000Source | -72,000,000Source | -611,000,000Source | -212,000,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation and amortization | — | — | — | — | — | — | —Source | —Source | —Source | —Source | —Source | —Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 52,000,000Source | 43,000,000Source | 216,000,000Source | 150,000,000Source | 132,000,000Source | 126,000,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -148,000,000Source | -110,000,000Source | 134,000,000Source | 216,000,000Source | 195,000,000Source | 57,000,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | 14,000,000Source | 30,000,000Source | 12,000,000Source | 267,000,000Source | 322,000,000Source | 198,000,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 132,000,000Source | 69,000,000Source | 6,000,000Source | -188,000,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | 230,000,000Source | 211,000,000Source | 1,400,000,000Source | 1,597,000,000Source | 1,032,000,000Source | -728,000,000Source |
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | — | — | — | — | — | — | — | 1,890,000,000Source | 45,000,000Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -139,000,000Source | -130,000,000Source | -595,000,000Source | -454,000,000Source | -2,145,000,000Source | -303,000,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 109,000,000Source | 115,000,000Source | 397,000,000Source | 337,000,000Source | 215,000,000Source | 218,000,000Source |
| Cash flows from financing activities: | ||||||||||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | — | — | — | — | — | — | 34,000,000Source | 16,000,000Source | 24,000,000Source | 26,000,000Source | 24,000,000Source | 31,000,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | -100,000,000Source | -146,000,000Source | -742,000,000Source | -868,000,000Source | 1,475,000,000Source | -474,000,000Source |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | — | — | — | — | — | — | -2,000,000Source | 0Source | -10,000,000Source | -11,000,000Source | -11,000,000Source | -11,000,000Source |
| Repayments of Long-term DebtUSD | — | — | — | — | — | — | 2,857,000,000Source | 168,000,000Source | 11,191,000,000Source | 1,460,000,000Source | 1,710,000,000Source | 7,846,000,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -13,000,000Source | -44,000,000Source | 124,000,000Source | 239,000,000Source | 371,000,000Source | -1,528,000,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 1,340,000,000Source | 750,000,000Source | 1,838,000,000Source | 1,743,000,000Source | 1,312,000,000Source | 1,157,000,000Source | 1,325,000,000Source | 1,201,000,000Source | 962,000,000Source | 591,000,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | — | — | 1,810,000,000Source | 1,674,000,000Source | 1,533,000,000Source | 1,540,000,000Source |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 163,000,000Source | — | — | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | — | — | — | -4,000,000Source | 21,000,000Source | 61,000,000Source | -36,000,000Source | 9,000,000Source | -23,000,000Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 43,000,000Source | 38,000,000Source | 54,000,000Source | 46,000,000Source | 52,000,000Source | 43,000,000Source | 216,000,000Source | 150,000,000Source | — | — |
| Amortization of Debt Issuance Costs and DiscountsUSD | — | — | — | — | — | — | 14,000,000Source | 15,000,000Source | 94,000,000Source | 55,000,000Source | 65,000,000Source | 99,000,000Source |
| DepreciationUSD | — | — | — | — | — | — | — | — | 207,000,000Source | 190,000,000Source | 187,000,000Source | 179,000,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | -7,000,000Source | 0Source | -7,000,000Source | -30,000,000Source | -11,000,000Source | -4,000,000Source | -52,000,000Source | -47,000,000Source | -52,000,000Source | -8,000,000Source |
| Gain (Loss) on Disposition of AssetsUSD | — | — | 6,000,000Source | 5,000,000Source | — | — | 3,000,000Source | 0Source | 6,000,000Source | 10,000,000Source | 3,000,000Source | 5,000,000Source |
| Gain (Loss) Related to Litigation SettlementUSD | — | — | -35,000,000Source | -188,000,000Source | -6,000,000Source | -8,000,000Source | -10,000,000Source | 3,000,000Source | -61,000,000Source | -220,000,000Source | 53,000,000Source | -9,000,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | 3,000,000Source | 0Source | 0Source | 178,000,000Source | -1,000,000Source | 0Source | 162,000,000Source | 23,000,000Source | 1,000,000Source | 875,000,000Source |
| GoodwillUSD | — | — | 11,287,000,000Source | 11,171,000,000Source | 9,793,000,000Source | 11,298,000,000Source | 9,807,000,000Source | 11,153,000,000Source | 11,271,000,000Source | 11,087,000,000Source | 11,183,000,000Source | 11,547,000,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | 1,426,000,000Source | — | 145,000,000Source | — | 493,000,000Source | 824,000,000Source |
| Income Tax Expense (Benefit)USD | — | — | 37,000,000Source | 71,000,000Source | 88,000,000Source | 12,000,000Source | 77,000,000Source | 39,000,000Source | 247,000,000Source | 239,000,000Source | 221,000,000Source | 83,000,000Source |
| Investment Income, InterestUSD | — | — | 15,000,000Source | 7,000,000Source | 11,000,000Source | 13,000,000Source | 10,000,000Source | 11,000,000Source | 48,000,000Source | 33,000,000Source | 26,000,000Source | 14,000,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | 179,000,000Source | -85,000,000Source | 258,000,000Source | 148,000,000Source | -1,423,000,000Source | -58,000,000Source | 157,000,000Source | -46,000,000Source | -592,000,000Source | -225,000,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | 2,000,000Source | -7,000,000Source | 2,000,000Source | -20,000,000Source | -8,000,000Source | -28,000,000Source | -37,000,000Source | -26,000,000Source | -19,000,000Source | 13,000,000Source |
| Other Nonoperating Income (Expense)USD | — | — | — | -225,000,000Source | — | — | — | — | -142,000,000Source | -247,000,000Source | -28,000,000Source | -35,000,000Source |
| Other Operating Income (Expense), NetUSD | — | — | -80,000,000Source | -225,000,000Source | -26,000,000Source | 18,000,000Source | -32,000,000Source | -15,000,000Source | -142,000,000Source | -247,000,000Source | -28,000,000Source | -35,000,000Source |
| Proceeds from Issuance of Long-term DebtUSD | — | — | — | — | — | — | 2,802,000,000Source | 50,000,000Source | 10,554,000,000Source | 661,000,000Source | 3,291,000,000Source | 6,836,000,000Source |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 2,681,000,000Source | 2,510,000,000Source | 2,852,000,000Source | 2,530,000,000Source | 2,524,000,000Source | 2,259,000,000Source | 10,266,000,000Source | 9,625,000,000Source | 8,757,000,000Source | 8,124,000,000Source |
| Selling, General and Administrative ExpenseUSD | — | — | 795,000,000Source | 850,000,000Source | 907,000,000Source | 894,000,000Source | 861,000,000Source | 867,000,000Source | 3,438,000,000Source | 3,296,000,000Source | 2,917,000,000Source | 2,625,000,000Source |
| Operating Income (Loss)USD | — | — | 619,000,000Source | 318,000,000Source | 740,000,000Source | 444,000,000Source | -950,000,000Source | 276,000,000Source | 1,813,000,000Source | 1,546,000,000Source | 963,000,000Source | 454,000,000Source |
| Other Nonoperating Income (Expense)USD | — | — | — | -225,000,000Source | — | — | — | — | -142,000,000Source | -247,000,000Source | -28,000,000Source | -35,000,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | 218,000,000Source | -21,000,000Source | 348,000,000Source | 140,000,000Source | -1,354,000,000Source | -47,000,000Source | 367,000,000Source | 167,000,000Source | -390,000,000Source | -129,000,000Source |
| Income Tax Expense (Benefit)USD | — | — | 37,000,000Source | 71,000,000Source | 88,000,000Source | 12,000,000Source | 77,000,000Source | 39,000,000Source | 247,000,000Source | 239,000,000Source | 221,000,000Source | 83,000,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | 2,000,000Source | -7,000,000Source | 2,000,000Source | -20,000,000Source | -8,000,000Source | -28,000,000Source | -37,000,000Source | -26,000,000Source | -19,000,000Source | 13,000,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | 179,000,000Source | -85,000,000Source | 258,000,000Source | 148,000,000Source | -1,423,000,000Source | -58,000,000Source | 157,000,000Source | -46,000,000Source | -592,000,000Source | -225,000,000Source |
| Earnings Per Share, BasicUSD per share | — | — | 0.48Source | -0.23Source | 0.69Source | 0.4Source | -3.82Source | -0.16Source | 0.42Source | -0.13Source | -1.62Source | -0.62Source |
| Earnings Per Share, DilutedUSD per share | — | — | 0.48Source | -0.23Source | 0.68Source | 0.4Source | -3.82Source | -0.16Source | 0.42Source | -0.13Source | -1.62Source | -0.62Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 371,300,000Source | 368,400,000Source | 375,000,000Source | 370,900,000Source | 372,800,000Source | 369,600,000Source | 370,900,000Source | 368,000,000Source | 364,900,000Source | 362,000,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 375,500,000Source | 368,400,000Source | 378,100,000Source | 373,100,000Source | 372,800,000Source | 369,600,000Source | 375,000,000Source | 368,000,000Source | 364,900,000Source | 362,000,000Source |
| Additional Financial Items | ||||||||||||
| Business Combination, Acquisition Related CostsUSD | — | — | 2,000,000Source | 2,000,000Source | 0Source | 2,000,000Source | 1,000,000Source | 1,000,000Source | 9,000,000Source | 4,000,000Source | 24,000,000Source | 29,000,000Source |
| Costs and ExpensesUSD | — | — | 2,062,000,000Source | 2,192,000,000Source | 2,112,000,000Source | 2,086,000,000Source | 3,474,000,000Source | 1,983,000,000Source | 8,453,000,000Source | 8,079,000,000Source | 7,794,000,000Source | 7,670,000,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 115,000,000Source | 170,000,000Source | 215,000,000Source | 271,000,000Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | — | — | — | — | 295,000,000Source | 305,000,000Source | 1,208,000,000Source | 1,267,000,000Source | 1,264,000,000Source | 1,394,000,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | -7,000,000Source | 0Source | -7,000,000Source | -30,000,000Source | -11,000,000Source | -4,000,000Source | -52,000,000Source | -47,000,000Source | -52,000,000Source | -8,000,000Source |
| Gain (Loss) Related to Litigation SettlementUSD | — | — | -35,000,000Source | -188,000,000Source | -6,000,000Source | -8,000,000Source | -10,000,000Source | 3,000,000Source | -61,000,000Source | -220,000,000Source | 53,000,000Source | -9,000,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | 1,426,000,000Source | — | 145,000,000Source | — | 493,000,000Source | 824,000,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -743,000,000Source | -596,000,000Source | -382,000,000Source | 64,000,000Source |
| Interest Expense, DebtUSD | — | — | 412,000,000Source | 346,000,000Source | 396,000,000Source | 465,000,000Source | 402,000,000Source | 330,000,000Source | 1,604,000,000Source | 1,388,000,000Source | 1,328,000,000Source | 1,464,000,000Source |
| Investment Income, InterestUSD | — | — | 15,000,000Source | 7,000,000Source | 11,000,000Source | 13,000,000Source | 10,000,000Source | 11,000,000Source | 48,000,000Source | 33,000,000Source | 26,000,000Source | 14,000,000Source |
| Other Operating Income (Expense), NetUSD | — | — | -80,000,000Source | -225,000,000Source | -26,000,000Source | 18,000,000Source | -32,000,000Source | -15,000,000Source | -142,000,000Source | -247,000,000Source | -28,000,000Source | -35,000,000Source |
Filing attachments
ex991-q32026.htm · 8-K · 2026-10-28
Investor Contact: Media Contact: Garen Sarafian Alexis Navratil ir@bauschhealth.com corporate.communications@bauschhealth.com (877) 281-6642 (toll free) (848) 264-0934 BAUSCH HEALTH ANNOUNCES THIRD QUARTER 2026 RESULTS, RAISES GUIDANCE • Third Quarter Consolidated Revenues of $2.94 billion, up 10% on a Reported basis and 8% on an Organic1 basis over the prior year period • GAAP Net Income Attributable to Bausch Health of $436 million and G…
Read attachment ↗ex991-q22026.htm · 8-K · 2026-07-29
EX-99.1 2 ex991-q22026.htm EX-99.1 Document Exhibit 99.1 Investor Contact: Media Contact: Garen Sarafian Katie Savastano ir@bauschhealth.com corporate.communications@bauschhealth.com (877) 281-6642 (toll free) (908) 541-3785 BAUSCH HEALTH ANNOUNCES SECOND QUARTER 2026 RESULTS, RAISES GUIDANCE • Second Quarter Consolidated Revenues of $2.85 billion, up 13% on a Reported basis and 11% on an Organic (non-GAAP)1 basis over the prior yea…
Read attachment ↗ex991-q1x2026.htm · 8-K · 2026-04-29
EX-99.1 2 ex991-q1x2026.htm EX-99.1 Document Exhibit 99.1 Investor Contact: Media Contact: Garen Sarafian Katie Savastano ir@bauschhealth.com corporate.communications@bauschhealth.com (877) 281-6642 (toll free) (908) 541-3785 BAUSCH HEALTH ANNOUNCES FIRST QUARTER 2026 RESULTS • First Quarter Consolidated Revenues of $2.52 billion, up 12% on a Reported basis and 7% on an Organic (non-GAAP)1 basis over the prior year period • GAAP Ne…
Read attachment ↗ex991-q4x2025.htm · 8-K · 2026-02-18
Exhibit 99.1 Investor Contact: Media Contact: Garen Sarafian Katie Savastano ir@bauschhealth.com corporate.communications@bauschhealth.com (877) 281-6642 (toll free) (908) 541-3785 BAUSCH HEALTH ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2025 RESULTS • Fourth Quarter Consolidated Revenues of $2.80 billion, up 9% on a Reported basis and up 6% on an Organic (non-GAAP)1 basis over the prior year period • Full-Year Consolidated Revenues of $10.…
Read attachment ↗d72478dex991.htm · 8-K · 2025-11-24
EX-99.1 2 d72478dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Investor Contact: Media Contact: Garen Sarafian Katie Savastano ir@bauschhealth.com corporate.communications@bauschhealth.com (877) 281-6642 (toll free) (908) 541-3785 Bausch Health Announces Launch of Offers to Exchange Certain Existing Senior Secured Notes LAVAL, QC, November 24, 2025 - Bausch Health Companies Inc. (NYSE: BHC)(TSX: BHC) (the “Company” or “Bausch Health”…
Read attachment ↗ex991-q3x2025.htm · 8-K · 2025-10-29
EX-99.1 2 ex991-q3x2025.htm EX-99.1 Document Exhibit 99.1 Investor Contact: Media Contact: Garen Sarafian Katie Savastano ir@bauschhealth.com corporate.communications@bauschhealth.com (877) 281-6642 (toll free) (908) 541-3785 BAUSCH HEALTH ANNOUNCES THIRD QUARTER 2025 RESULTS • Third Quarter Consolidated Revenues of $2.68 billion, up 7% on a Reported basis and 5% on an Organic (non-GAAP)1 basis over the prior year period • GAAP Net…
Read attachment ↗